News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|September 1, 2001

Should we offer HRT to ovarian and endometrial cancer survivors? Yes.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

SMFM in midst of first annual High-Risk Pregnancy Awareness Week | Image credit: Stock.adobe.com

SMFM in midst of first annual High-Risk Pregnancy Awareness Week

ByJoshua Fitch, Senior Editor

June 3rd 2026

Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds | Image credit: Stock.adobe.com

Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds

ByJoshua Fitch, Senior Editor

June 3rd 2026

Individualized TRT demonstrates broad symptom improvements beyond sexual function

Individualized TRT demonstrates broad symptom improvements beyond sexual function

ByMelissa Loseke, DO

June 2nd 2026

Acetaminophen remains first-line medication for pain, fever in pregnancy, SMFM says | Image credit: Stock.adobe.com

Acetaminophen remains first-line medication for pain, fever in pregnancy, SMFM says

ByJoshua Fitch, Senior Editor

June 1st 2026

FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI

FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI

ByJoshua Fitch, Senior Editor

June 1st 2026

Latest CME

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Washington

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Washington

Alison K. Conlin, MD; Neil M. Iyengar, MD

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Wyoming & Montana

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Wyoming & Montana

Yan Ji, MD; Neil M. Iyengar, MD

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – North Carolina

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – North Carolina

Girish Kunapareddy, MD; Sara M. Tolaney, MD, MPH

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI

Individualized TRT demonstrates broad symptom improvements beyond sexual function

Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds

Acetaminophen remains first-line medication for pain, fever in pregnancy, SMFM says

Transdermal Hormone Therapy for VMS and Cardiovascular Risk Management